$ALXO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALX ONCOLOGY HOLDINGS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALX ONCOLOGY HOLDINGS INC. Get notifications about new insider transactions in ALX ONCOLOGY HOLDINGS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 58.92 | 10,353 | 609,976 | 511,246 | 521.6 K to 511.2 K (-1.98 %) |
Jun 22 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 58.06 | 6,347 | 368,504 | 521,599 | 527.9 K to 521.6 K (-1.20 %) |
Jun 15 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Option Exercise | A | 59.66 | 12,004 | 716,159 | 12,004 | |
Jun 15 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | A | 59.66 | 12,004 | 716,159 | 12,004 | |
May 11 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 64.56 | 73 | 4,713 | 186,363 | 186.4 K to 186.4 K (-0.04 %) |
May 11 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 62.79 | 956 | 60,026 | 186,436 | 187.4 K to 186.4 K (-0.51 %) |
May 11 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 62.12 | 4,433 | 275,378 | 187,392 | 191.8 K to 187.4 K (-2.31 %) |
May 11 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 61.12 | 1,925 | 117,654 | 191,825 | 193.8 K to 191.8 K (-0.99 %) |
May 05 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pinto Shelly | VP, Finance and CAO | Option Exercise | A | 62.83 | 125,000 | 7,853,750 | 125,000 | |
Apr 21 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 60.48 | 837 | 50,618 | 544,646 | 545.5 K to 544.6 K (-0.15 %) |
Apr 21 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 59.52 | 663 | 39,460 | 545,483 | 546.1 K to 545.5 K (-0.12 %) |
Apr 21 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 58.36 | 2,914 | 170,054 | 546,146 | 549.1 K to 546.1 K (-0.53 %) |
Apr 21 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 57.73 | 6,956 | 401,568 | 549,060 | 556 K to 549.1 K (-1.25 %) |
Apr 21 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Sell | S | 56.42 | 5,330 | 300,733 | 556,016 | 561.3 K to 556 K (-0.95 %) |
Apr 13 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 63.51 | 284 | 18,037 | 193,750 | 194 K to 193.8 K (-0.15 %) |
Apr 13 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 61.59 | 259 | 15,953 | 194,034 | 194.3 K to 194 K (-0.13 %) |
Apr 13 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 60.29 | 2,941 | 177,299 | 194,293 | 197.2 K to 194.3 K (-1.49 %) |
Apr 13 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 59.15 | 1,000 | 59,148 | 197,234 | 198.2 K to 197.2 K (-0.50 %) |
Apr 13 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 58.06 | 2,903 | 168,541 | 198,234 | 201.1 K to 198.2 K (-1.44 %) |
Mar 26 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Option Exercise | M | 0.99 | 10,000 | 9,900 | 242,179 | |
Mar 26 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Buy | M | 0.99 | 10,000 | 9,900 | 561,346 | 551.3 K to 561.3 K (+1.81 %) |
Mar 26 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Option Exercise | M | 0.99 | 10,000 | 9,900 | 242,179 | |
Mar 26 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Buy | M | 0.99 | 10,000 | 9,900 | 561,346 | 551.3 K to 561.3 K (+1.81 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | M | 1.91 | 16,700 | 31,897 | 89,019 | |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 70.12 | 600 | 42,075 | 551,346 | 551.9 K to 551.3 K (-0.11 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 69.77 | 9,200 | 641,857 | 551,946 | 561.1 K to 551.9 K (-1.64 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 68.27 | 2,700 | 184,329 | 561,146 | 563.8 K to 561.1 K (-0.48 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 67.18 | 1,500 | 100,773 | 563,846 | 565.3 K to 563.8 K (-0.27 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 66.33 | 600 | 39,795 | 565,346 | 565.9 K to 565.3 K (-0.11 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 64.98 | 900 | 58,486 | 565,946 | 566.8 K to 565.9 K (-0.16 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Sell | S | 63.79 | 1,200 | 76,545 | 566,846 | 568 K to 566.8 K (-0.21 %) |
Mar 24 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Buy | M | 1.91 | 16,700 | 31,897 | 568,046 | 551.3 K to 568 K (+3.03 %) |
Mar 12 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 76.69 | 100 | 7,669 | 201,137 | 201.2 K to 201.1 K (-0.05 %) |
Mar 12 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 75.20 | 1,146 | 86,177 | 201,237 | 202.4 K to 201.2 K (-0.57 %) |
Mar 12 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 74.35 | 4,844 | 360,151 | 202,383 | 207.2 K to 202.4 K (-2.34 %) |
Mar 12 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Sell | S | 73.38 | 1,297 | 95,177 | 207,227 | 208.5 K to 207.2 K (-0.62 %) |
Jan 28 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Option Exercise | M | 0.99 | 10,000 | 9,900 | 252,179 | |
Jan 28 2021 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President & CEO | Buy | M | 0.99 | 10,000 | 9,900 | 551,346 | 541.3 K to 551.3 K (+1.85 %) |
Dec 15 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Buy | P | 76.00 | 20,000 | 1,520,000 | 995,000 | 975 K to 995 K (+2.05 %) |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 38,660 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 664,660 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 18,705 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 137,286 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 11,110 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 150,801 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 8,175 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 59,998 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 39,758 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 683,523 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 222,752 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,633,743 | 0 | 0 | |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 111,528 | 0 | 120,212 | 8.7 K to 120.2 K (+1,284.29 %) |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | P | 19.00 | 22,000 | 418,000 | 22,000 | 0 to 22 K |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 1,498,984 | 0 | 2,023,469 | 524.5 K to 2 M (+285.80 %) |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | P | 19.00 | 378,000 | 7,182,000 | 378,000 | 0 to 378 K |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 249,632 | 0 | 309,222 | 59.6 K to 309.2 K (+418.92 %) |
Jul 22 2020 | ALXO | ALX ONCOLOGY HOLDI ... | LSV Associates, LLC | 10% Owner | Buy | C | 0.00 | 1,831,027 | 0 | 2,268,087 | 437.1 K to 2.3 M (+418.94 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,158,851 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | P | 19.00 | 185,526 | 3,524,994 | 185,526 | 0 to 185.5 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | C | 0.00 | 3,245,048 | 0 | 4,034,522 | 789.5 K to 4 M (+411.04 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Vivo Capital IX, LLC | 10% Owner | Buy | P | 19.00 | 789,474 | 15,000,006 | 789,474 | 0 to 789.5 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Option Exercise | C | 0.00 | 2,105,901 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Buy | P | 19.00 | 975,000 | 18,525,000 | 975,000 | 0 to 975 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Buy | C | 0.00 | 2,105,901 | 0 | 2,161,981 | 56.1 K to 2.2 M (+3,755.17 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Hemrajani Rekha | Director | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 52,647 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 15,794 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 1,052,950 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 490,411 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 2,398,588 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | C | 0.00 | 3,100,020 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 52,647 | 0 | 54,083 | 1.4 K to 54.1 K (+3,666.23 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 93,969 | 0 | 113,287 | 19.3 K to 113.3 K (+486.43 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 3,941,949 | 0 | 5,268,325 | 1.3 M to 5.3 M (+297.20 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | P | 19.00 | 850,000 | 16,150,000 | 850,000 | 0 to 850 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Buy | C | 0.00 | 3,100,020 | 0 | 3,969,789 | 869.8 K to 4 M (+356.42 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Option Exercise | C | 0.00 | 10,529 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Buy | C | 0.00 | 10,529 | 0 | 11,254 | 725 to 11.3 K (+1,452.28 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 5,264 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 1,803 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Option Exercise | C | 0.00 | 20,225 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President and CEO | Buy | C | 0.00 | 27,292 | 0 | 541,346 | 514.1 K to 541.3 K (+5.31 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 38,660 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 664,660 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 18,705 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 137,286 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 10,529 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 11,110 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 150,801 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 8,175 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 59,998 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 39,758 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 683,523 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 222,752 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 1,633,743 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 111,528 | 0 | 120,212 | 8.7 K to 120.2 K (+1,284.29 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | P | 19.00 | 22,000 | 418,000 | 22,000 | 0 to 22 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 1,498,984 | 0 | 2,023,469 | 524.5 K to 2 M (+285.80 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | P | 19.00 | 378,000 | 7,182,000 | 378,000 | 0 to 378 K |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 249,632 | 0 | 309,222 | 59.6 K to 309.2 K (+418.92 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 1,831,027 | 0 | 2,268,087 | 437.1 K to 2.3 M (+418.94 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Buy | C | 0.00 | 88,704 | 0 | 107,220 | 18.5 K to 107.2 K (+479.07 %) |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 1,052,950 | 0 | 0 | ||
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 490,411 | 0 | 0 | ||
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 2,398,588 | 0 | 0 | ||
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 3,100,020 | 0 | 0 | ||
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Option Exercise | C | 0.00 | 78,175 | 0 | 0 | ||
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | P | 19.00 | 3,000 | 57,000 | 99,406 | 96.4 K to 99.4 K (+3.11 %) | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | P | 19.00 | 850,000 | 16,150,000 | 5,268,325 | 4.4 M to 5.3 M (+19.24 %) | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 3,941,949 | 0 | 4,418,325 | 476.4 K to 4.4 M (+827.49 %) | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 3,100,020 | 0 | 3,969,789 | 869.8 K to 4 M (+356.42 %) | |
Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Adelman Robert J | Buy | C | 0.00 | 78,175 | 0 | 96,406 | 18.2 K to 96.4 K (+428.80 %) | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Graham G. Walmsley | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Nielsen Jack | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Lettmann Jason | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GOODMAN COREY S | Director | Option Exercise | A | 19.00 | 24,009 | 456,171 | 24,009 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Randolph Sophia | Chief Medical Offic ... | Option Exercise | A | 19.00 | 89,657 | 1,703,483 | 89,657 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 19.00 | 41,789 | 793,991 | 41,789 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 19.00 | 88,137 | 1,674,603 | 88,137 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Caffo Nathan | Chief Business Offi ... | Option Exercise | A | 19.00 | 22,794 | 433,086 | 22,794 | |
Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pons Jaume | President &CEO | Option Exercise | A | 19.00 | 272,771 | 5,182,649 | 272,771 |
Page: 1